Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-12

Clinical Trial Update: Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating single-dose intravenous iron isomaltoside plus oral iron versus oral iron alone for anemia after postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron isomaltoside (iron isomaltoside)

Snippet

Sponsor: University of Malaya | Conditions: Post Partum Hemorrhage, Anemia | Phase 4 | Status: UNKNOWN